How Alzheimer's Abeta propagates and triggers tau pathology in intact neurons

Tomoya Sasahara,Shoko Hongo,Mika Ito,Naomi Takino,Shin-ichi Muramatsu,Akiyoshi Kakita,Minako Hoshi
DOI: https://doi.org/10.1101/2024.08.28.608712
2024-08-29
Abstract:Alzheimer's disease begins with Abeta accumulation, progresses to tau aggregates and results in widespread neurodegeneration (1-3). Simultaneous propagation of Abeta aggregates from very limited to wide and distant brain regions is one of the outstanding events in the early stage. Here, we demonstrate that the neurovascular unit (4,5) comprising capillaries and pericytes, the machinery supplying oxygen and glucose to neurons, is also the machinery for propagating effector molecules that impose Alzheimer's pathologies on intact neurons. We discovered two distinct signaling cascades, one activated in capillary endothelial cells and the other in pericytes. At the origin of either cascade, we identified amylospheroid (ASPD) (6,7), a highly toxic 30-mer assembly of Abeta, and its sole target NKAalpha3 (8), a neuron-specific isoform of Na+,K+-ATPase (9,10) but present in endothelial cells and pericytes. In endothelial cells, ASPD binding to NKAalpha3 releases angiotensin II, which increases beta-secretase in intact neurons, causing a huge increase of AbetaSUB42 and resultant accumulation. In pericytes, ASPD binding to NKAalpha3 releases an unknown effector molecule that activates delta-secretase in intact neurons, further augmenting Abeta42 and producing pathogenic tau1-368 fragment. Thus, Abeta and tau pathologies are directly linked. Stopping the signaling cascades near the origin by inhibiting ASPD-NKAalpha3 interaction (8) may provide a new therapeutic approach.
Neuroscience
What problem does this paper attempt to address?